Select therapeutic use:

Benign prostatic hyperplasia/urinary retention:

Indications for: Terazosin

Benign prostatic hyperplasia (BPH).

Adult Dosage:

See full labeling. Initially 1mg at bedtime. Titrate to 10mg once daily; usual max 20mg/day. Reevaluate if no response after 6 weeks.

Children Dosage:

Not applicable.

Terazosin Warnings/Precautions:

Rule out prostate cancer. Syncope.

Terazosin Classification:

Alpha-1 blocker.

Terazosin Interactions:

Caution with verapamil, other antihypertensives.

Adverse Reactions:

Syncope (esp. 1st dose), dizziness, somnolence, asthenia, nausea, nasal congestion, palpitations, impotence, orthostatic hypotension, blurred vision, peripheral edema; priapism (rare).

Note:

Formerly known under the brand name Hytrin.

Metabolism:

Hepatic (minimal).

Drug Elimination:

Fecal (60%), renal (40%). Half life: ~12hrs.

How Supplied:

Contact supplier

Hypertension:

Indications for: Terazosin

Hypertension.

Adult Dosage:

1 mg at bedtime, then increase slowly. Usually: 1–5mg once daily in the AM; max 20mg/day. Monitor at peak (2–3 hours after dose) and trough. If BP response is substantially diminished at 24 hours, may increase dose or give in 2 divided doses. If hypotensive effects occur at peak, consider twice daily dosing. If another antihypertensive is added, dosage reduction and retitration may be necessary.

Children Dosage:

Not recommended.

Terazosin Warnings/Precautions:

Syncope. Pregnancy (Cat.C). Nursing mothers.

Terazosin Classification:

Alpha-1 blocker.

Terazosin Interactions:

Caution with verapamil, other antihypertensives.

Adverse Reactions:

Syncope (esp. 1st dose), dizziness, somnolence, asthenia, nausea, nasal congestion, palpitations, orthostatic hypotension, blurred vision, peripheral edema; priapism (rare).

Note:

Formerly known under the brand name Hytrin.

Metabolism:

Hepatic (minimal).

Drug Elimination:

Fecal (60%), renal (40%). Half life: ~12hrs.

How Supplied:

Contact supplier